drugset / Trial / NCT03262727
The Effect of BMS-986165 Combined With an Oral Contraceptive (Ethinyl Estradiol/Norethindrone) in Healthy Female Patients
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to investigate the effect of BMS-986165 in combination with an oral contraceptive in healthy female patients.
Timeline
- Start
- 2017-09-01
- Primary completion
- 2017-11-23
- Completion
- 2017-12-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CRAVACITINIB | Small molecule | — | Oral |
| Subject | Loestrin | Unknown | 30 ug | Oral |
| Subject | Loestrin | Unknown | 1.5 mg | Oral |